Letermovir Intravenous and Lorcaserin Extended-Release Tablets
Determining the interaction of Letermovir Intravenous and Lorcaserin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letermovir
Brand name: Prevymis
Synonyms: Letermovir (oral/injection), Letermovir
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Letermovir Intravenous-Lorcaserin Hydrochloride
- Letermovir Intravenous-Lorcaserin Tablets
- Letermovir Intravenous-Lorcet
- Letermovir Intravenous-Lorcet Plus
- Letermovir Intravenous-Lorcet Tablets
- Letermovir Intravenous-Lorlatinib
- Lorcaserin Extended-Release Tablets-Letermovir oral/injection
- Lorcaserin Extended-Release Tablets-Letermovir Tablets
- Lorcaserin Extended-Release Tablets-Letrozole
- Lorcaserin Extended-Release Tablets-Letrozole and ribociclib
- Lorcaserin Extended-Release Tablets-Leucovorin
- Lorcaserin Extended-Release Tablets-Leucovorin Calcium